One- to 2-hour postprandial blood glucose concentrations and glycosylated hemoglobin require monitoring to assess efficacy.Â Serum transaminase concentrations should be checked every three months for the first year of therapy. The clinician should decrease the dose or discontinue therapy if concentrations become elevated during treatment.